Closed · DARPA-BAA-12-33 · CFDA 12.910 · Discretionary

In vivo Nanoplatforms for Diagnostics (IVN:Dx)

Federal grant opportunity posted by DARPA - Microsystems Technology Office, cataloged on Grants.gov.

Varies
Award range
Closed
Status
June 28, 2012
Close date
-
Expected awards

The verdict

In vivo Nanoplatforms for Diagnostics (IVN:Dx) is a closed discretionary listing from DARPA - Microsystems Technology Office that offered Varies by applicant. Future funding cycles may be published under the same CFDA number. PlainGrants indexes 110 other opportunities from DARPA - Microsystems Technology Office.

Varies
award range
Closed
application status
12.910
CFDA program
110
other opportunities from DARPA - Microsystems Technology Office

Archived opportunity record

In vivo Nanoplatforms for Diagnostics (IVN:Dx) is closed (last close June 28, 2012). Check the agency catalog for replacement NOFOs. DARPA - Microsystems Technology Office still indexes 110 other opportunities here.

According to Grants.gov (extract vintage 2026-08-10), this record reflects the officially published listing. See methodology.

Deadline tracker

Application window closed

Closed June 28, 2012

Posted Mar 15 Closes Jun 28

Instrument

Procurement Contract

Description

The specific objective of the In vivo Nanoplatforms for Diagnostics (IVN:Dx) thrust of the In vivo Nanoplatforms (IVN) program is to develop biocompatible nanosensors that provide continuous, noninvasive, and highly accurate measurement of a variety of conditions and substances within the living tissue of animals, plants, and insects using non-toxic materials with limited immunogenicity. These sensors will permit qualitative and quantitative assessment over large concentration ranges of both small (e.g., glucose, lactate, and urea) and large molecules (e.g., proteins, oligonucleotides, infectious agents, and chemical/biological threat agents) in the organism and environment through optical, electronic, thermal or magnetic mechanisms. See full DARPA-BAA-12-33 attached.

Catch-all / unrestricted eligibility mark · DARPA-BAA-12-33

Grants.gov marks In vivo Nanoplatforms for Diagnostics (IVN:Dx) with a catch-all / unrestricted eligibility code (Unrestricted / see official listing). Read the official announcement text for the real applicant filter — the code alone is not a door list. The extract does not mark applicant cost-sharing as required. Instrument: Procurement Contract. Funding-activity code maps to Science and Technology / R&D (ST). This eligibility-code string dominates the DARPA - Microsystems Technology Office book (80 peers, 72% of 111).

Code 99
Unrestricted / see official listing

Codes are Grants.gov eligibility category values from the extract vintage 2026-08-10. Confirm the full eligibility statement on the official listing or the Grants.gov eligibility reference.

Official Listing on Grants.gov

View full details, application forms, and submission instructions.

View on Grants.gov

Agency Contact

Dr. Timothy Broderick Program Manager

What to do next

In vivo Nanoplatforms for Diagnostics (IVN:Dx) is closed; use the parent program and agency catalog for the next funding cycle.

  • Browse open federal opportunities in the same category when this listing is closed. Open opportunities
  • Look up CFDA 12.910 across all indexed listings before you commit to this opportunity alone. Eligibility finder
  • Compare award ranges across federal categories before you pick a single CFDA. All categories

Opportunity deadlines and eligibility change on Grants.gov; PlainGrants mirrors the extract and is not the submission system.

Disclaimer: This information is sourced from Grants.gov and SAM.gov and is for informational purposes only. Opportunity details, deadlines, and eligibility requirements change frequently. Always verify current information directly on Grants.gov before applying. PlainGrants is not affiliated with any federal agency.

Data sourced from the SAM.gov Assistance Listings and Grants.gov. See our methodology for details. Retrieved and formatted by PlainGrants